Actinolactomycin from Streptomyces sp. CB00271: Isolation, Identification, and Potent Anti-Triple-Negative Breast Cancer
Molecules · 2026
DOI: 10.3390/molecules31040631 ↗Kurz gefasst
Fachartikel in der Zeitschrift Molecules, 2026. Verfasst von Bang Gong und 5 weiteren Autor:innen. Beteiligte Einrichtung: College of Pharmacy, Hunan Vocational College of Science and Technology, Changsha 410004, China. Hauptthemen laut MEDLINE: Streptomyces, Triple Negative Breast Neoplasms, Antineoplastic Agents. Die Arbeit nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: the Natural Science Foundation of Hunan Province, the Hunan Provincial Department of Education Science Research Project, the "Liu Liang Academician Workstation" Mentorship Program.
Abstract (Originalsprache)
Triple-negative breast cancer (TNBC) is a highly aggressive subtype with limited targeted therapies, underscoring an urgent need for novel agents. The soil-derived Streptomyces sp. CB00271, isolated from a biodiversity hotspot, was investigated for its bioactive metabolites. Bioassay-guided isolation led to the identification of actinolactomycin (1), alongside daidzein (2) and genistein (3). Remarkably, actinolactomycin (1) exhibited potent cytotoxicity against TNBC models, with IC50 values of 0.72 ± 0.12 μM (MDA-MB-231) and 0.15 ± 0.02 μM (4T1), demonstrating approximately 9-fold and 31-fold greater potency than cisplatin, respectively, and suggesting action through targeted pathway inhibition. This study constitutes the first report to systematically highlight the exceptional anti-TNBC potential of this rare natural product, establishing it as a promising lead compound against this challenging subtype. Furthermore, Streptomyces sp. CB00271 is identified as a valuable and scarce microbial resource for actinolactomycin, providing a new avenue to address its supply limitation and facilitate future development.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- College of Pharmacy, Hunan Vocational College of Science and Technology, Changsha 410004, China.
- Xiangya International Academy of Translational Medicine, Central South University, Changsha 410013, China.
- Hunan Province Sino-US International Joint Research Center for Therapeutic Drugs of Senile Degenerative Diseases, School of Pharmacy, Hunan University of Chinese Medicine, Changsha 410208, China.
Förderung
- the Natural Science Foundation of Hunan Province
- the Hunan Provincial Department of Education Science Research Project
- the "Liu Liang Academician Workstation" Mentorship Program
- Hunan Provincial Department of Education Science Research Project
- Hunan Provincial Natural Science Foundation of China
- “Liu Liang Academician Workstation” Mentorship Program
Zitieren
APA
Gong, B., Pan, J., Zhang, J., Ren, S., Tang, Y., & Jiang, L. (2026). Actinolactomycin from Streptomyces sp. CB00271: Isolation, Identification, and Potent Anti-Triple-Negative Breast Cancer. Molecules. https://doi.org/10.3390/molecules31040631
Vancouver
Gong B, Pan J, Zhang J, Ren S, Tang Y, Jiang L. Actinolactomycin from Streptomyces sp. CB00271: Isolation, Identification, and Potent Anti-Triple-Negative Breast Cancer. Molecules. 2026. doi:10.3390/molecules31040631
BibTeX
@article{Gong2026,
author = {Gong, Bang and Pan, Jian and Zhang, Jun and Ren, Shujuan and Tang, Yingnan and Jiang, Lin},
title = {Actinolactomycin from Streptomyces sp. CB00271: Isolation, Identification, and Potent Anti-Triple-Negative Breast Cancer},
journal = {Molecules},
year = {2026},
doi = {10.3390/molecules31040631}
}
EUVIMED